Xenetic Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $806 | $766 | $1,026 | $589 |
Gross Profit | 806 | 766 | 1,026 | 589 |
EBITDA | -456 | -579 | -523 | -688 |
EBIT | -509 | |||
Net Income | -456 | -579 | -509 | -688 |
Net Change In Cash | 806 | 766 | 1,026 | 589 |
Free Cash Flow | -536 | -242 | -658 | -383 |
Cash | 7,347 | 7,883 | 4,121 | 4,779 |
Basic Shares | 2,291 | 2,291 | 1,542 | 1,542 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,976 | $2,500 | $2,539 | $1,706 |
Gross Profit | 2,976 | 2,500 | 2,539 | 1,706 |
EBITDA | -2,680 | -3,806 | -4,134 | -6,525 |
EBIT | -3,960 | -4,487 | -6,552 | |
Net Income | -2,680 | -3,960 | -4,134 | -6,552 |
Net Change In Cash | 2,976 | 2,500 | 2,539 | 1,706 |
Free Cash Flow | -2,286 | -2,817 | -4,114 | -5,146 |
Cash | 7,883 | 6,165 | 8,983 | 13,097 |
Basic Shares | 1,701 | 1,541 | 1,528 | 1,422 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.19 |
2025-12-31 | -$0.22 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.45 |